p38 mitogen activated protein kinase mapk inhibitor sb202190 (Enzo Biochem)
Structured Review

P38 Mitogen Activated Protein Kinase Mapk Inhibitor Sb202190, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p38 mitogen activated protein kinase mapk inhibitor sb202190/product/Enzo Biochem
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Epithelial cell senescence impairs repair process and exacerbates inflammation after airway injury"
Article Title: Epithelial cell senescence impairs repair process and exacerbates inflammation after airway injury
Journal: Respiratory Research
doi: 10.1186/1465-9921-12-78

Figure Legend Snippet: P38 MAPK inhibitor suppresses senescence-associated airway inflammation in mice . ( A ) Representative photomicrographs of double immunofluorescence staining for phospho-p38 MAPK ( green ) and CC10 ( red ) in the distal airway. Arrows indicate CC10-positive Clara cells that express phospho-p38 MAPK in their nuclei. Treatment with SB202190 of mice repeatedly exposed to NA and injected with BrdU reduces the proportion of Clara cells that express phospho-p38 MAPK ( B ) and the numbers of CD45-positive cells and CD90.2-positive cells infiltrating the distal airways ( C ) but does not affect the number of Clara cells ( D ) or the number of Clara cells that express p21 ( E ). Data are expressed as the means ± SEM. N = 4-6 in each experiment.
Techniques Used: Mouse Assay, Double Immunofluorescence Staining, Injection

Figure Legend Snippet: P38 MAPK activation in senescent Clara cells in the airways of COPD patients . ( A ) Representative photomicrographs of triple immunofluorescence staining of lung tissue sections obtained from COPD patients. Arrows indicate CC10-positive Clara cells that express both p16 and phospho-p38 MAPK. The arrowhead indicates a CC10-positive cell that expresses p16 but not phospho-p38 MAPK ( B ) Percentages of CC10-positive Clara cells that express p16, CC10-positive Clara cells that express phospho-p38 MAPK, and CC10-positive Clara cells that express both p16 and phospho-p38 MAPK in the lungs of COPD patients ( C : n = 14), asymptomatic smokers ( S : n = 7), and asymptomatic nonsmokers ( NS : n = 8). ( C ) Correlation between the percentage of CC10-positive Clara cells that express p16 and the percentage of CC10-positive Clara cells that express phospho-p38 MAPK. Open circles = asymptomatic nonsmokers; open triangles = asymptomatic smokers; closed circles = COPD patients. ( D ) Rates of immunopositivity for phospho-p38 MAPK in CC10-positive Clara cells that express p16 (senescent Clara cells) and in CC10-positive Clara cells that do not express p16 (presenescent Clara cells) in the subjects as a whole, asymptomatic nonsmokers, asymptomatic smokers, and COPD patients.
Techniques Used: Activation Assay, Immunofluorescence, Staining

Figure Legend Snippet: Senescence of NCI-H441 cells after exposure to BrdU for 10 days is accompanied by p38 MAPK-dependent pro-inflammatory cytokine production . ( A ) ELISA to measure concentrations of IL-6, TNF-α, and GM-CSF in the culture supernatants of NCI-H441 cells exposed or not exposed to 25 μM of BrdU in the presence or absence of 10 μM of the p38 MAPK inhibitor SB202190. The concentration of the anti-inflammatory cytokine IL-10 was below the limit of detection. ( B ) Immunoblot analyses for phosphorylation levels of p38 MAPK and NF-κB in the cell lysates. ( C ) Effects of SB202190 on BrdU-induced SA β-gal activation and growth arrest. Data are expressed as the means ± SEM. N = 3-6 in each experiment.
Techniques Used: Enzyme-linked Immunosorbent Assay, Concentration Assay, Activation Assay
![... cells. Genotoxic stress caused by BrdU also activates p38-MAPK pathways that trigger the production of pro-inflammatory cytokines/chemokines, ... Pathways by which BrdU impairs epithelial repair and induces persistent inflammation in the chronic NA injury model . BrdU induces genotoxic stress, which activates the DNA damage response, thereby promoting premature senescence, which results in the growth arrest of epithelial cells. Genotoxic stress caused by BrdU also activates p38-MAPK pathways that trigger the production of pro-inflammatory cytokines/chemokines, which exacerbate inflammation. Which is necessary for p38-MAPK activation, the DNA damage response or cell cycle arrest (p21, etc.), has not been determined ( broken arrows ). Recent evidence indicates that pro-inflammatory cytokines (e.g., IL-6, IL-8) at least in part reinforce cell cycle arrest via the DNA damage response pathway [ 32 , 33 ], suggesting a positive feedback loop ( dashed arrow ) in which inflammation in turn promotes senescence.](https://storage.googleapis.com/bioz_article_images/PMC3118351/1465-9921-12-78-10.jpg)
Figure Legend Snippet: Pathways by which BrdU impairs epithelial repair and induces persistent inflammation in the chronic NA injury model . BrdU induces genotoxic stress, which activates the DNA damage response, thereby promoting premature senescence, which results in the growth arrest of epithelial cells. Genotoxic stress caused by BrdU also activates p38-MAPK pathways that trigger the production of pro-inflammatory cytokines/chemokines, which exacerbate inflammation. Which is necessary for p38-MAPK activation, the DNA damage response or cell cycle arrest (p21, etc.), has not been determined ( broken arrows ). Recent evidence indicates that pro-inflammatory cytokines (e.g., IL-6, IL-8) at least in part reinforce cell cycle arrest via the DNA damage response pathway [ 32 , 33 ], suggesting a positive feedback loop ( dashed arrow ) in which inflammation in turn promotes senescence.
Techniques Used: Activation Assay
Related Articles
Recombinant:Article Title: Regulation of Transcription Factor Twist Expression by the DNA Architectural Protein High Mobility Group A2 during Epithelial-to-Mesenchymal Transition * Article Snippet: The mutants M2 (TTT to CCC) and M3 (TTCTTTT to CCCTCCC) were reconstituted into the Twist −95/+209 promoter by PCR-based site-specific mutagenesis (Stratagene), according to the manufacturer's instructions. .. Recombinant mature TGFβ1 was from BIOSOURCE Inc. Small molecular weight inhibitors: SB505124 against the three type I receptor kinases of the TGFβ family, known as activin receptor-like 4, 5, and 7, was from Sigma; SB202190 against the Molecular Weight:Article Title: Regulation of Transcription Factor Twist Expression by the DNA Architectural Protein High Mobility Group A2 during Epithelial-to-Mesenchymal Transition * Article Snippet: The mutants M2 (TTT to CCC) and M3 (TTCTTTT to CCCTCCC) were reconstituted into the Twist −95/+209 promoter by PCR-based site-specific mutagenesis (Stratagene), according to the manufacturer's instructions. .. Recombinant mature TGFβ1 was from BIOSOURCE Inc. Small molecular weight inhibitors: SB505124 against the three type I receptor kinases of the TGFβ family, known as activin receptor-like 4, 5, and 7, was from Sigma; SB202190 against the other:Article Title: Differential transcriptional regulation of hypoxia-inducible factor-1α by arsenite under normoxia and hypoxia: involvement of Nrf2 Article Snippet: The specific inhibitors for the mitogen-activated protein kinase (MEK) U0126 and PD98059, the Article Title: Reduction of p38 mitogen-activated protein kinase and cyclooxygenase-2 signaling by isoflurane inhibits proliferation and apoptosis evasion in human papillomavirus-infected laryngeal papillomas Article Snippet: SB202190, a specific inhibitor of Injection:Article Title: Epithelial cell senescence impairs repair process and exacerbates inflammation after airway injury Article Snippet: This BrdU administration schedule was chosen because epithelial proliferation in mice is maximal 1 to 2 days after exposure to NA [ ]. .. The |